Answers are grounded in this paper and cite their sources.
Investigates emodin's role in intestinal barrier protection in neonatal rats, suggesting therapeutic potential.
Background Neonatal necrotizing enterocolitis (NEC) is a common and severe gastrointestinal disorder in newborns, for which there is currently no effective treatment. Emodin (EMD) can alleviate inflammation and intestinal damage, but its role and regulatory mechanism in NEC still need to be explored. Purpose To investigate the guardian influence of EMD on the intestinal mucosal barrier in neonatal rats with NEC and its relationship with mitochondrial autophagy mediated by phosphatase and tensin homolog-induced putative kinase 1 (PINK1)/Parkin pathway. Materials and Methods Sprague–Dawley (SD) neonatal rats were split into control, NEC, low-dose EMD, medium-dose EMD, and high-dose EMD groups at a venture. Apart from the control group, the NEC rat models were constructed in the other groups and given different doses of EMD by gavage. The weight changes of rats were measured; intestinal permeability was measured by fluorescein isothiocyanate (FITC)-glucan; the contents of diamine oxidase (DAO), d -lactic acid (D-LA), endotoxin (ET), and inflammatory factors in serum were tested by enzyme-linked immunosorbent assay (ELISA); real-time fluorescence quantitative polymerase chain reaction (PCR) was utilized for detecting zonula occludens-1 (ZO-1) and occludin expression in small intestine; the expression levels of PINK1, Parkin, microtubule-associated protein 1A/1B-light chain 3 (LC3II), and Beclin1 were tested using western blot. Results In comparison with control rats, the weight of rats in the NEC group was visibly lessened, the concentration of FITC, intestinal mucosal injury indicators (D-LA, DAO, ET), and contents of pro-inflammatory indicators (interleukin-6 [IL-6], interleukin-1 beta [IL-1β], tumor necrosis factor-alpha [TNF-α]) in serum, protein expression of LC3II, Beclin1, PINK1, and Parkin in intestinal tissues were overtly increased, whereas the expression of ZO-1 and occludin in intestinal tissues was overtly lessened. The body weight, expression of ZO-1 and occludin in intestinal tissues, and levels of LC3II, Beclin1, PINK1, and Parkin protein in the EMD low-, medium-, and high-dosage groups were overtly enhanced versus those in the NEC group, while the concentration of FITC, DAO activity, levels of D-LA, ET, IL-1β, IL-6, and TNF-α in serum were distinctly reduced. Conclusion EMD can reduce the inflammatory reaction, improve the intestinal mucosal permeability, promote mitochondrial autophagy, and serve as a guardian part in the body of neonatal rats with NEC.
No takes yet. Share an insight, caveat, or question.
Qiu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: